IL13 and irritable bowel syndrome: Further, increased levels of IL-5 and IL-13 and decreased interferon-γ (IFN-γ) production following lymphocyte stimulation was reported in the combined FD and IBS cohort when compared to controls (Kindt et al., 2009).